Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
Recombinant human erythropoietin has been used for more than two decades in clinical practice with promising results in the treatment of anemia associated with chronic renal insufficiency and in patients with cancer. Recent evidence has uncovered new nonhematopoietic functions of this protein and ha...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2010-07-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/1158 |